Alpha DNA Investment Management’s iShares MSCI Emerging Markets ETF EEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,322
Closed -$123K 257
2021
Q1
$123K Buy
2,322
+414
+22% +$22.7K 0.14% 115
2020
Q4
$98K Buy
+1,908
New +$91.7K 0.1% 134

Other funds holding EEM

Alpha DNA Investment Management's EEM Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of iShares MSCI Emerging Markets ETF (EEM) in Q2 2021, closing a stake of 2,322 shares — an estimated $123K sold.

Alpha DNA Investment Management first reported a position in EEM in Q4 2020 and held it in 2 quarters. The position peaked at $123K in Q1 2021. 1,332 funds tracked by Wall St. Rank hold EEM as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining iShares MSCI Emerging Markets ETF position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 2,322 iShares MSCI Emerging Markets ETF shares in Q2 2021, an estimated $123K.
  • Alpha DNA Investment Management first reported a position in iShares MSCI Emerging Markets ETF in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's iShares MSCI Emerging Markets ETF position peaked at $123K in Q1 2021.
  • 1,332 funds tracked by Wall St. Rank held iShares MSCI Emerging Markets ETF as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.